• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 May 20;27(8).
doi: 10.3201/eid2708.210965. Online ahead of print.
Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia

Zheng Quan Toh, Rachel A Higgins, Lien Anh Ha Do, Karin Rautenbacher, Francesca L Mordant, Kanta Subbarao, Kate Dohle, Jill Nguyen, Andrew C Steer, Shidan Tosif, Nigel W Crawford, Kim Mulholland, Paul V Licciardi

Abstract

The duration of the humoral immune response in children infected with severe acute respiratory syndrome coronavirus 2 is unknown. We detected specific IgG 6 months after infection in children who were asymptomatic or had mild symptoms of coronavirus disease. These findings will inform vaccination strategies and other prevention measures.

Keywords: 2019 novel coronavirus disease; Australia; COVID-19; IgG; SARS-CoV-2; acute respiratory infections; antibodies; children; coronavirus disease; coronaviruses; humoral immune responses; persistence; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom